Recently, researchers at the Institute of Pharmacology and Regenerative Medicine of the Tomsk National Research Medical Center of the Russian Academy of Sciences discovered that inhalation of xenon gas can effectively treat pulmonary ventilation dysfunction, and developed a device for performing the operation accordingly. The new technology is globally unique and extremely low cost.
Respiratory failure and resulting hypoxemia (acute COVID-19 symptoms or post-COVID-19 symptoms) are currently treated with oxygen therapy, nitric oxide, helium, exogenous surfactants, and antiviral and anticytokine drugs specific variants of the treatment. However, the effectiveness of these methods is open to debate.
Vladimir Udut, MD, deputy director of the Institute of Pharmacology and Regenerative Medicine at the Tomsk National Research Medical Center, said performing a procedure that increases blood oxygen saturation requires understanding how this effect is achieved. and understand the mechanisms that improve oxygen supply when the lungs are damaged.
At the end of 2020, researchers at Tomsk University discovered that patients who were infected with the new coronavirus and developed mental disorders and felt great pressure had significantly improved respiratory function after xenon inhalation treatment.
Xenon is a rare gas, and xenon is the last chemical element in the fifth period of the periodic table. Due to the tropism (attachment) to many specific receptors, xenon can regulate the excitability of nerve tissue, and play a hypnotic and anti-stress effect, thereby preventing neurological diseases.
The researchers found that due to xenon‘s unique ability to restore gas exchange between the alveoli and capillaries and the function of surfactant (a substance that lines the alveoli and protects the alveoli from closing due to low surface tension during exhalation), So as to achieve the therapeutic effect. In this way, xenon inhalation creates the necessary conditions for the transfer of oxygen from the inhaled air into the blood, an effect that can be seen with conventional pulse oximeters.
Udut said that currently, there is no similar technology in global practice, and the inhalation device can be produced with a 3D printer at low cost. Hypoxemia during respiratory failure induces stress and thus confusion. Stress and delirium can be prevented by eliminating lung ventilation dysfunction with xenon gas.
Post time: Dec-28-2022
